Plasma heparanase is associated with blood glucose levels but not urinary microalbumin excretion in type 2 diabetic nephropathy at the early stage
- PMID: 28994624
- PMCID: PMC6446149
- DOI: 10.1080/0886022X.2017.1384391
Plasma heparanase is associated with blood glucose levels but not urinary microalbumin excretion in type 2 diabetic nephropathy at the early stage
Abstract
Aim: To explore the possible correlations between plasma heparanase and albuminuria, glucose and lipid metabolism in the type 2 diabetic nephropathy patients at the early stage.
Methods: One hundred and forty patients with type 2 diabetic nephropathy at early stage were recruited into the study. Plasma heparanase and the characterized advanced glycation end products (AGEs), carboxymethyllysine (CML) were measured by enzyme-linked immunosorbent assay.
Results: Plasma heparanase was positively associated with fasting blood glucose (R = 0.24, p = .01) while heparanase was not significantly correlated with the urinary microalbumin to creatinine ratio (urinary mAlb/Cr) (R = 0.05, p = .58) and CML (R = 0.16, p = .26). On stepwise linear regression analysis, fasting blood glucose was the main independent determinants of plasma heparanase concentration.
Conclusion: Plasma heparanase is not significantly associated with urinary mAlb/Cr while it is correlated positively with blood glucose levels in the early stage of diabetic nephropathy. Plasma heparnase might be regarded as a marker for vascular endothelial cells injury in diabetic patients.
Keywords: Diabetic nephropathy; albuminuria; heparanase.
Similar articles
-
Plasma sRAGE is not associated with urinary microalbumin excretion in type 2 diabetic nephropathy at the early stage.Diabetes Res Clin Pract. 2010 Feb;87(2):157-60. doi: 10.1016/j.diabres.2009.11.002. Epub 2009 Nov 28. Diabetes Res Clin Pract. 2010. PMID: 19945761
-
Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.Diabet Med. 2004 Jun;21(6):545-51. doi: 10.1111/j.1464-5491.2004.01200.x. Diabet Med. 2004. PMID: 15154937
-
[Value of plasma growth differentiation factor-15 in diagnosis and evaluation of type 2 diabetic nephropathy].Nan Fang Yi Ke Da Xue Xue Bao. 2014 Mar;34(3):387-90. Nan Fang Yi Ke Da Xue Xue Bao. 2014. PMID: 24670455 Chinese.
-
Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy.Metabolism. 2011 Aug;60(8):1064-9. doi: 10.1016/j.metabol.2010.11.002. Epub 2011 Jan 19. Metabolism. 2011. PMID: 21251686
-
Endocan and albuminuria in type 2 diabetes mellitus.Ren Fail. 2016 Nov;38(10):1647-1653. doi: 10.1080/0886022X.2016.1229966. Epub 2016 Oct 18. Ren Fail. 2016. PMID: 27756187
Cited by
-
Serum Heparanase Level Is Decreased in Stable Coronary Artery Disease.Med Princ Pract. 2019;28(6):573-580. doi: 10.1159/000503085. Epub 2019 Sep 4. Med Princ Pract. 2019. PMID: 31480068 Free PMC article.
-
Serum Levels of Nε-(Carboxymethyl)-Lysine in Chronic Kidney Disease and Type 2 Diabetes Mellitus.Biomedicines. 2025 Jul 8;13(7):1672. doi: 10.3390/biomedicines13071672. Biomedicines. 2025. PMID: 40722744 Free PMC article.
-
Endothelial glycocalyx in retina, hyperglycemia, and diabetic retinopathy.Am J Physiol Cell Physiol. 2023 May 1;324(5):C1061-C1077. doi: 10.1152/ajpcell.00188.2022. Epub 2023 Mar 20. Am J Physiol Cell Physiol. 2023. PMID: 36939202 Free PMC article. Review.
-
In-hospital mortality in elderly patients with acute kidney injury requiring dialysis: a cohort analysis.Int Urol Nephrol. 2020 Jun;52(6):1117-1124. doi: 10.1007/s11255-020-02482-2. Epub 2020 May 5. Int Urol Nephrol. 2020. PMID: 32372303
-
Retinal Physiology and Circulation: Effect of Diabetes.Compr Physiol. 2020 Jul 8;10(3):933-974. doi: 10.1002/cphy.c190021. Compr Physiol. 2020. PMID: 32941691 Free PMC article. Review.
References
-
- Gross JL, de Azevedo MJ, Silveiro SP, et al. . Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28:164–176. - PubMed
-
- American Diabetes Association. Standards of medical care in diabetes–2014. Diabetes Care. 2014;37(Suppl. 1):S14–S80. - PubMed
-
- Ziyadeh FN, Wolf G.. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev. 2008;4:39–45. - PubMed
-
- Wada T, Shimizu M, Toyama T, et al. . Clinical impact of albuminuria in diabetic nephropathy. Clin Exp Nephrol. 2012;16:96–101. - PubMed
-
- Jefferson JA, Shankland SJ, Pichler RH.. Proteinuria in diabetic kidney disease: a mechanistic viewpoint. Kidney Int. 2008;74:22–36. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical